戻る
Oculis Holding AG (OCS)価格
OCS 株価推移チャート
OCS 収入
Oculis Holding AG
$25.22
5.78%
$1.37
終値： Jan 16, 16:00:00 GMT-5
$25.25
0.11%
$0.03
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$23.84
始値
$23.82
当日レンジ
$23.69 - $26.17
52週レンジ
$14 - $26.17
取引高
428.1K
平均取引高
133.1K
1株当たり利益(TTM)
-2.17
配当利回り
--
時価総額
$1.4B
OCSとは何ですか？
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 49 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.